Assessment of Skin Barrier Disruption Due to Daily Use of Cleaning Products and Hand Disinfectants

NCT ID: NCT06269315

Last Updated: 2024-02-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-04-01

Study Completion Date

2025-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to assess the effects of household detergents and hand disinfectants on human skin barrier integrity among healthy adult volunteers.

The main questions it aims to answer are:

* How does exposure to household detergents and hand disinfectants impact skin barrier function?
* Are there differences in skin barrier disruption between various types of cleaning agents and disinfectants?

Participants will:

Undergo patch testing with controlled amounts of household detergents and hand disinfectants on a small area of their skin.

Be monitored for adverse reactions during and after exposure. Have their skin barrier integrity assessed using electrical impedance spectroscopy at multiple time points post-exposure.

If there is a comparison group:

Researchers will compare the effects of different types of cleaning agents, hand disinfectants, and their ingredients on skin barrier integrity to determine variations in their impact.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

1. Core Message:

Understanding the effects of detergent and disinfectant exposure on skin barrier integrity is crucial for public health, particularly given their widespread use.
2. Supporting Information:

Studies suggest an association between cleaning agents and skin barrier disruption. Skin barrier function can be assessed using various methods, including electrical impedance spectroscopy (EIS).
3. Key Points:

Scientific Question: Investigate how household detergent, hand disinfectant, and their ingredients exposure affect skin barrier function.

Proposed Intervention: Conduct controlled human skin exposure experiments with properly diluted household detergents, hand disinfectants, and their ingredients.

Scientific Basis: Previous research indicates potential risks associated with cleaning agent exposure and validates EIS as a suitable assessment tool.
4. Objectives:

Hypothesis: Household detergent and hand disinfectant exposure damage skin barrier integrity.

Primary Objective: Demonstrate the effect of cleaning agent exposure on skin barrier function.
5. Study Population and Procedures:

Inclusion criteria: Healthy adult volunteers aged 18-65. Exclusion criteria: Individuals with chronic skin conditions, allergies, or recent systemic therapy.

Recruitment through ongoing processes and physician referrals. Informed consent emphasizing voluntary participation and the right to withdraw.
6. Statistics and Methodology:

Sample size: 50 participants. Intervention: Participants will be exposed to controlled amounts of household detergents, hand disinfectants, and their ingredients.

Assessment methods: EIS for skin barrier integrity evaluation. Statistical methods: Analysis using appropriate tests to detect significant differences.
7. Regulatory Aspects and Safety:

Compliance with ethical guidelines and local regulations. Immediate reporting of adverse events and regular safety monitoring.
8. Quality Control and Data Protection:

Measures include personnel training, SOPs, and data security protocols. Data is handled with discretion and stored securely.
9. Monitoring and Registration:

Regular monitoring by research institutions (SIAF and UZH). This study will be registered with the Swiss National Clinical Trial Portal (SNCTP via BASEC) and ClinicalTrials.gov.
10. Funding / Publication / Declaration of Interest:

Funding from Swiss National Foundation (Prof. Cezmi Akdis) and SciBase. Commitment to transparency, open science, and conflict-free reporting. Multicentre collaboration between SIAF and Department of Dermatology, UZH.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Control Condition (PBS) Household Detergent Exposure Hand Disinfectant Exposure Surfactant Exposure Other Ingredients Exposure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

1. Skin Cleansing and Testing Patch Preparation:

Prepare a test set of patch testing tapes, each containing a small amount of a different household cleaner, hand disinfectant, their ingredients, and control with proper dilution. The safety dose of the tested products and agents will be defined beforehand.

Before exposure, selected areas of forearm skin will be cleaned and moistened. Electrical impedance will be measured by electrical impedance spectroscopy (EIS) to assess skin barrier integrity.
2. Patch Application:

Apply the prepared patches on the skin of the forearm. Patches will be removed after 5 minutes of exposure.

During the exposure period, subjects will be instructed not to touch, wash, or wet the exposed area to avoid interfering with the action of the testing reagents. 3. Patch Removal and Post-Exposure Monitoring:

The patch will be gently removed from the skin. Exposed areas of skin will be evaluated by EIS at specific times up to 24 hours after the treatment.
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Exposure arm

Prepared test products, such as household cleaner, hand disinfectant, their ingredients, and control on patch testing tapes will be posted on the selected areas of forearm skin.

Group Type EXPERIMENTAL

Cleaning product exposure

Intervention Type OTHER

Exposure of a small amount of a different household cleaner, hand disinfectant, their ingredients, and control with proper dilution on forearm of donors

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cleaning product exposure

Exposure of a small amount of a different household cleaner, hand disinfectant, their ingredients, and control with proper dilution on forearm of donors

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The study population will consist of healthy adult volunteers; 1. age between18 and 65 years, 2. Generally healthy and able to provide written informed consent. The choice of healthy adult volunteers without pre-existing skin conditions on site or allergies against tested products is justified.

Exclusion Criteria

1. Severe dermatitis, eczema, psoriasis, or other chronic skin conditions.
2. History of hypersensitivity or allergies to tested product ingredients.
3. Current or recent systemic therapy for a skin condition in the past six months.
4. Pregnant or breastfeeding individuals.
5. Use of investigational drugs or participation in another trial in the last 30 days.
6. History of skin cancer or malignancies in the study area.
7. Significant sunburn, open wounds, or active skin infections in the study area.
8. Any medical condition that, per the investigator, might compromise safety or confound results.
9. Inability to follow study instructions or attend required clinic visits.
10. Gender Balance: To ensure gender balance, efforts will be made to recruit an equal number of male and female participants.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Zürich

OTHER

Sponsor Role collaborator

Swiss Institute of Allergy and Asthma Research

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Swiss Institute of Allergy and Asthma Research

Davos, Kanton Graubünden, Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yasutaka Mitamura, MD PhD

Role: CONTACT

41 81 410 0848

Cezmi A Akdis, MD professor

Role: CONTACT

+41 (0) 81 410 08 48

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yasutaka Mitamura, MD PhD

Role: primary

+41 (0) 81 410 08 48

Cezmi A Akdis, MD professor

Role: backup

+41 (0) 81 410 08 48

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SBDDCP

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Glycyrrhetinic Acid and Acute Irritant Dermatitis
NCT07286487 NOT_YET_RECRUITING NA